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Impact of Patient-Prosthesis
Mismatch and Aortic Valve Design on
Coronary Flow Reserve After Aortic Valve Replacement
Farhad Bakhtiary, MD,* Mirko Schiemann, MD,† Omer Dzemali, MD,* Selami Dogan, MD,*
Volker Schächinger, MD, PHD,‡ Hans Ackermann, MD, PHD,§ Anton Moritz, MD, PHD,*
Peter Kleine, MD, PHD*
Frankfurt/Main, Germany
Objectives This prospective-randomized study investigated the effect of aortic valve design and patient-prosthesis mismatch
(PPM) on coronary flow reserve (CFR) after mechanical or biological aortic valve replacement (AVR) in patients
with aortic stenosis (AS).
Background Coronary flow reserve may be an important parameter of long-term survival after AVR in patients with AS. Re-
duced CFR may contribute to more cardiovascular events and greater rates of mortality.
Methods A total of 48 patients undergoing AVR underwent magnetic resonance imaging for the measurement of coronary
flow preoperatively, 5 days postoperatively, and at 6-month follow-up with measurement of CFR. Patients sched-
uled for mechanical AVR were randomized to a tilting disc or bileaflet prosthesis (n  12 in each group). For
biological AVR, patients were scheduled to receive a stented (n  12) or stentless (n  12) valve. Patients also
underwent echocardiography with measurement of transvalvular pressure gradients and left ventricular mass
regression.
Results Postoperatively, coronary flow increased significantly in all groups (p  0.001). Only stentless valves demon-
strated a normal CFR (3.4  0.3 vs. 2.3  0.1 for stented biological valves, 2.1  0.2 for tilting disc, and 2.2 
0.3 for bileaflet mechanical valves). Patient-prosthesis mismatch with an indexed effective orifice area 0.85
cm2/m2 led to decreased rates of CFR in the tilting disc, stentless, and stented groups. Pressure gradients were
14  3 mm Hg for tilting disc, 12  4 mm Hg for bileaflet, 19  6 mm Hg for stented, and 10  4 mm Hg for
stentless valves.
Conclusions Normalization of CFR after AVR in patients with AS was observed only for stentless valves. Coronary flow reserve
might explain the excellent long-term results for stentless valves. (Impact of Patient-Prosthesis Mismatch on
Coronary Flow Reserve; http://www.clinicaltrials.gov/ct/show/NCT00310947?order1; NCT00310947)
(J Am Coll Cardiol 2007;49:790–6) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.052u
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cmpairment of coronary flow reserve (CFR) in patients with
ortic stenosis and left ventricular hypertrophy is related to
ortic valve area and peak transvalvular gradients rather than
he degree of left ventricular hypertrophy (1). Reduced CFR
as been defined to be an independent predictor of cardio-
ascular prognosis within the next decade (2).
Long-term mortality is increased in patients after aortic
alve replacement (AVR) compared with the normal pop-
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hysiology, and §Department of Biomedical Statistics, Johann Wolfgang Goethe
niversity Hospital, Frankfurt/Main, Germany. This work was supported in part by
edtronic Inc., Minneapolis, Minnesota.a
Manuscript received July 20, 2006; revised manuscript received September 13,
006, accepted October 16, 2006.lation (3,4). Findings from trials conducted in the 1970s
nd 1980s seemed to demonstrate that valve design did not
nfluence long-term outcome, but recent studies observed
arying mortality between different stented biological valve
ubstitutes (5,6). Also, the impact of patient-prosthesis
ismatch (PPM) with an indexed effective orifice area
iEOA) 0.85 cm2/m2 on survival has been the topic of
ontroversy (7,8). However, the role of PPM on coronary
erfusion and especially CFR has not been investigated,
lthough an inadequate valve opening will cause turbulent
ortic root flow and thus also might impair physiological
ackflow during diastole.
Chronic coronary hypoperfusion and reduced CFR might
ontribute to cardiac events such as sudden cardiac death or
rrhythmias. Furthermore, deteriorating left ventricular
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February 20, 2007:790–6 Aortic Valve Replacement and Coronary Flow Reserveunction is common after AVR and might be related to
nsufficient coronary flow. Our own previous experimental
tudies showed that postoperative coronary flow and coro-
ary reserve are dependent on valve design and orientation.
one of the tested aortic valve prostheses allowed for
hysiological coronary flow rates (9–12).
The aim of this prospective, randomized study was to
nvestigate the impact of valve design and PPM on CFR
nd hemodynamic performance in patients undergoing
VR for aortic stenosis. We compared 2 mechanical and 2
iological valves and evaluated the acute and chronic
hanges in coronary artery flow, CFR, hemodynamic out-
ome, and regression of left ventricular mass in patients
ndergoing AVR who did not have coronary artery disease.
Noninvasive measurement of coronary perfusion rates in
ivo can be performed either by echocardiography or mag-
etic resonance imaging (MRI). Echocardiography fre-
uently is limited by impaired postoperative conditions of
nalysis. Therefore, we used MRI scanning because it
rovides a more objective measurement of right and left
oronary artery flow rates in patients without their addi-
ional exposure to X-rays (13,14).
ethods
rom March 2003 to January 2005, 48 patients undergoing
VR were included in this prospective randomized study.
atients suffered from severe aortic stenosis (maximum
radient 50 mm Hg or aortic valve area 1.0 cm2); no
atient had more than minimal aortic regurgitation and, all
atients, a preoperative coronary angiography demonstrated
he absence of any coronary artery obstruction. Exclusion
riteria included active endocarditis, emergency surgery, and
history of coronary artery disease or myocardial infarction.
he hypothesis of our study was that less downstream
urbulence achieved by stentless valves contributes to im-
roved coronary flow. The study was approved by the ethics
ommittee of the Johann Wolfgang Goethe University
ospital (Frankfurt/Main, Germany) and all patients pro-
ided written informed consent before inclusion.
Transthoracic echocardiography and MRI scanning were
erformed on the day of admission, before discharge, and
uring a 6-month follow-up visit. The MRI scan was used
o measure coronary flow rates and dynamics. Additional
easurement of adenosine-induced CFR (140 g/kg/min
denosine over the course of 7 min) was performed during
he follow-up MRI. Rate-pressure product (RPP) as the
roduct of heart rate multiplied by left ventricular pressure
systolic blood pressure  systolic transvalvular gradient)
as calculated as an indicator of myocardial oxygen
emand. The intention was to exclude increased cardiac
ork load as the cause of increased coronary flow rates.
e used echocardiography to evaluate the hemodynam-
cs of the valves and left ventricular mass regression
LVMR). At the follow-up visits, additional clinical
valuation was performed. mchocardiography. Echocar-
iography was executed accord-
ng to American Society of
chocardiography guidelines us-
ng a Wingmed Vivid 5 cardiac
ltrasound scanner (GE Medi-
als, Fairfield, Connecticut).
ontinuous-wave Doppler was
sed to derive peak transvalvular
ressure gradients across the aor-
ic valve (peak aortic valve gradi-
nt). Aortic valve area was calcu-
ated according to the American
ollege of Cardiology/American
eart Association guidelines to
etermine severity of aortic ste-
osis. Effective orifice area was
alculated using the continuity equation method. The iEOA
as derived by dividing EOA by the body surface area. Left
entricular ejection time was measured on the continuous-wave
oppler trace, from opening to closure of the aortic valve.
he mean of 3 separate readings in case of sinus rhythm and
he mean of 5 separate readings in case of atrial fibrillation
ere used for each parameter. All data collected were
ntered in a central database.
ardiovascular magnetic resonance (cMRI scan). Pa-
ients were examined in a 1.5-T system (Magnetom Sonata,
aestro Class; Siemens, Erlangen, Germany) in a supine
osition using thoracic surface coils. The examination
tarted with a set of transverse and double oblique scout
mages to localize the coronary arteries. Subsequently, a
etrospectively ECG-gated breath hold phase-contrast flash
equence with high temporal and spatial resolution was used
o acquire flow data. These sequences were oriented per-
endicularly to the left (segment 5) and right (segment 1)
oronary artery main stems. Resulting cMRI flow data sets
ncluded rephased, magnitude, and phase images and were
egmented manually using the ARGUS flow analysis soft-
are (Houston, Texas). According to the measured veloci-
ies at every time frame, velocity and flow curves were
enerated and analyzed. The preoperative measured values
f coronary flow for each individual patient were set as 100%
alues. The postoperative values were then related to these
reoperative flow rates. Coronary flow reserve was calcu-
ated as the ratio between maximum and rest coronary flow
ates. Additionally, the distance of the coronary flow veloc-
ty peak to the R-wave was measured representing the time
f maximal coronary flow in relation to systole and diastole.
The reproducibility of the described MRI technique of
oronary flow rate evaluation has been reported recently
14). Patients were either selected for mechanical or biolog-
cal valve replacement depending on their age, risk of
nticoagulation, and life expectancy. This selection was
erformed according to the institutional standards. Ran-
omization started after this process. Patients scheduled for
Abbreviations
and Acronyms
AVR  aortic valve
replacement
CFR  coronary flow
reserve
iEOA  indexed effective
orifice area
LVMR  left ventricular
mass regression
MRI  magnetic resonance
imaging
PPM  patient-prosthesis
mismatch
RPP  rate-pressure
productechanical valve replacement (n  24) were randomized to
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Aortic Valve Replacement and Coronary Flow Reserve February 20, 2007:790–6eceive a Medtronic Hall tilting disc or Medtronic Advan-
age bileafleat valve. Also, in the biological group (n  24),
atients were randomized for either a porcine stented
ioprostheses (Medtronic Mosaic) or a porcine stentless
alve (Medtronic Freestyle; all valves by Medtronic Inc.,
inneapolis, Minnesota). The most important features of
he implanted valves are listed in Table 1.
Both biological valves undergo identical processing with
ero pressure cusp fixation and amino-oleic acid anticalci-
cation treatment. Intraoperatively, patients were excluded
rom the study if their aortic root wall had severe calcifica-
ions that could not be removed surgically and thus made
he implantation of a stentless valve impossible or if their
ortic root was dilated.
urgical technique. A total of 9 surgeons performed the
perations using partial upper sternotomy, standard extra-
orporeal circulation, retrograde cold blood cardioplegia,
nd carbon dioxide insufflation of the open chest to mini-
ize organ damage caused by air embolism. Access to the
ortic valve was gained via a transverse aortotomy. After
omplete resection of the native aortic valve and debride-
ent of the aortic annulus, accurate sizing was conducted
sing the original sizers for the 4 different valves. Hall,
dvantage, and Mosaic valves were implanted in a supra-
nnular fashion using interrupted pledget-armed U stitches
ith Ethibond 2-O sutures (Ethicon, Inc., Cornelia, Geor-
ia). Bites were taken from the ventricular to the aortic side
f the annulus. For the 2 mechanical valves, optimum
rientation was chosen according to previous publications
11). Freestyle valves were implanted in the modified
ubcoronary position, leaving the noncoronary prosthetic
inus intact. Single Ethibond 4-O sutures (Ethicon) for the
roximal and a running Prolene 4-O suture (Ethicon) for
he distal anastomoses were used. No oversizing for stentless
alves was performed.
tatistical methods. As a first step of statistical analysis,
aussian normal distributions of results obtained for hemo-
ynamic parameters and coronary flow rates were tested
sing the Dallal-Wilkinson corrected, Kolmogoroff-
mirnoff test (15). Data were compiled and analyzed using
icrosoft Excel (Redmond, Washington) and Statview
he Most Important Features of the Implanted Valves
Table 1 The Most Important Features of the Implanted Valves
Hall Advantag
Design Mechanical
Tilting Disc Bileaflet
Material Polycarbon leaflets
Titanium housing
First implant 1977 1999
Characteristics Requires optimal
orientation, good
hemodynamics
Low profile
Low thrombog
Easy implantat
Larger central
OA  alpha-aminooleic acid (anticalcification treatment).Cary, North Carolina). The baseline characteristics and tospital outcomes for the 4 groups were compared using
hi-square contingency or the Fisher exact test for categor-
cal data and Mann-Whitney U test or Kruskal-Wallis test
or continuous variables. Results are reported as the mean
D in text and tables. Statistical significance was defined as
p  0.05.
esults
reoperative coronary artery flow and also other clinical
haracteristics, including gender, body surface area, ejection
raction (EF), New York Heart Association functional class,
nd cardiovascular risk factors were comparable in the 4
roups (Table 2); the only significant difference was ob-
erved with respect to lower age in the 2 mechanical groups.
oronary flow rates varied distinctly between individuals,
ut mean and median values were similar. Evaluation of the
oronary perfusion pattern demonstrated a pathological
arly flow velocity peak (distance from the R-wave 375 ms
or Hall, 390 ms for Advantage, 380 ms for Mosaic, and 390
s for Freestyle). Flow was even partially reversed during
ystole: mean RPP was 19,885  4,558 beats/min·mm Hg,
gain, with no differences between groups.
Each of the 4 valves was implanted into 12 patients,
espectively. Because of the more complex implantation
echnique, cross-clamp times and cardiopulmonary bypass
imes were significantly longer in the stentless valve group.
he mean valve sizes were 24  1.8 mm for tilting disc,
3.5  1.5 mm for bileaflet, 23  1.6 mm for the stented
roup, and 24  1.1 mm for the stentless group. Because
nly the stentless sizers were metric, Hall, Advantage, and
osaic, sizes had to be converted into their metric values
16,17), which were 21.2  1.4 for Hall, 21  1.3 for
dvantage, and 20.6 1.0 mm for Mosaic. Thus, Freestyle
alves demonstrated significantly greater implanted diame-
ers (p  0.05), with the remaining valve sizes comparable.
The discharge MRI evaluation of coronary flow revealed
significant increase in coronary flow for each individual
atient (p  0.001). The preoperative values were set as
00%. Figure 1 demonstrates that coronary artery flow
ncreased to 185  23% for Hall, 182  19% for Advan-
Mosaic Freestyle
Porcine biological
Stented Stentless
Porcine leaflets, treated with
physiological fixation and
AOA
1994 1992
Good midterm
outcome
Excellent hemodynamic
performance,
laminar flowe
enicity
ion
orificeage, 224  37% for Mosaic, and 245  28% for Freestyle
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February 20, 2007:790–6 Aortic Valve Replacement and Coronary Flow Reservealves. The 2 biological valves showed a significantly greater
ncrease (related to the preoperative values) in flow rates
ompared with the mechanical groups (p  0.01); the
ifference in favor of the stentless group compared with the
tented biological valve also was significant (p 0.05). Both
he left and right coronary artery demonstrated similar
esults. At the follow-up examination, coronary flow rates
ere lower compared with the discharge evaluation (mean
46  19% of preoperative values for Hall, 156  24% for
dvantage, 188  39% for Mosaic, and 215  35% for the
reesytle group), with the difference between the valve
roups being maintained. The stentless valve demonstrated
ignificantly greater coronary flow rates compared with the
reoperative Patient Characteristics
Table 2 Preoperative Patient Characteristics
Hall (n  12) A
Male 8
Female 4
Age (yrs) 62 4.5
BSA 1.98 0.25
Angina pectoris 4
Hypertension 8
Valvular gradient (mm Hg) 65 19
NYHA functional class 3 0.5
Coronary flow RCA (ml/min) 59 28
Coronary flow LCA (ml/min) 85 28
Preoperative ejection fraction (echocardiography, %) 63 12
Diabetes 4
Smoking 5
p  0.05.
BSA  body surface area; LCA  left coronary artery; NS  nonsignificant; NYHA  New York H
Figure 1 Comparison of Pre- With Postoperative
Flow Rates for the 4 Valve Designs
Preoperative flow rates were set as 100%. A significant increase was observed
for all valves postoperatively. Postoperative flow rates were significantly greater
for biological valves compared with the mechanical groups (*p  0.01) and
within the biological group for stentless prosthesis (†p  0.05). At follow-up,
coronary flow was lower compared with the early postoperative phase with the
Advantage in favor of the stentless valve compared with the 3 other substi-
tutes being maintained (‡p  0.05).ther 3 valve designs. Coronary flow rates at rest were
omparable 6 months postoperatively (left coronary artery
ow 75  11 ml/min for Hall, 81  14 ml/min for
dvantage, 78  13 ml/min for Mosaic, and 88  17
l/min for Freestyle; RCA flow 48  8 ml/min for Hall,
1 11 ml/min for Advantage, 42  8 ml/min for Mosaic,
nd 51  11 ml/min for Freestyle). Coronary flow reserve
Fig. 2) induced by Adenosine was normal (2.5) only for
tentless valves (3.4  0.3), whereas the remaining groups
howed reduced values (2.1  0.2 for Hall, 2.2  0.3 for
dvantage, and 2.3  0.1 for Mosaic valves). Hemody-
amic data at the time of CFR measurement were recorded,
nd no significant differences were observed among the 4
roups regarding heart rate (mean 76 beats/min for Hall, 72
eats/min for Advantage, 74 beats/min for Mosaic, and 77
eats/min for Freestyle), arterial blood pressure (mean 78
m Hg for Hall, 75 mm Hg for Advantage, 78 mm Hg for
osaic, and 72 mm Hg for Freestyle) and peripheral
xygen saturation (variation between 93% and 98% in all
roups).
ge (n  12) Mosaic (n  12) Freestyle (n  12) p Value
5 5 5 NS
7 7 7 NS
3 5 *76 6 *71 7 *
4 0.2 1.90 0.1 1.85 0.2 NS
6 6 7 NS
6 7 7 NS
3 11 69 22 73 14 NS
8 0.3 2.5 0.5 2.8 0.4 NS
3 18 65 21 60 30 NS
0 41 90 33 94 31 NS
9 14 60 10 52 5 NS
4 6 5 NS
6 5 7 NS
ssociation; RCA  right coronary artery.
Figure 2 CFR 6 Months Postoperatively
Only the stentless Freestyle valve showed a normal coronary flow reserve (CFR)
2.5; the remaining 3 valve designs demonstrated comparable results with
slightly reduced CFR.dvanta
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Aortic Valve Replacement and Coronary Flow Reserve February 20, 2007:790–6Patient-prosthesis mismatch with an iEOA 0.85 cm2/m2
ccurred in 3 Hall (25%), 1 Advantage (8.3%), 3 Freestyle
25%), and 4 Mosaic (33.3%) patients. Figure 3 summarizes
he results of CFR in patients with or without PPM. Except
or the Advantage group, with only 1 patient demonstrating
PM, there was a clear decrease in CFR for patients with an
EOA0.85 cm2/m2. However, for the stentless valves, CFR
emained within normal ranges (2.9  0.3).
The coronary flow pattern changed in both groups
ostoperatively toward a more diastolic velocity peak of
erfusion with no more reversed systolic coronary flow. The
eak flow velocity distance from the R-wave increased to
50 ms for Hall, 530 ms for Advantage, 550 ms for Mosaic,
nd 570 ms for Freestyle. There were no significant differ-
nces between the 4 valve groups.
All echocardiographic results are summarized in Table 3.
ean gradients for the 2 mechanical valves were compara-
le, whereas Freestyle valves demonstrated significantly
ower results at discharge and at the 6-month follow-up
p  0.01). Left ventricular mass index regressed signifi-
antly in all groups over time. However, there were no
ignificant differences in LVMR between the groups at
ither discharge or 6 months postoperatively, although a
rend for more pronounced LVMR was observed for Free-
tyle valves.
Rate-pressure product decreased for all patients toward
ormal values without any significant differences (Hall
0,114  1,102 beats/min·mm Hg; Advantage 9,166  964
Figure 3 Reduced CFR in Patients With PPM for Hall Tilting
Disc, Mosaic Stented, and Freestyle Stentless Valves
The results for stentless valves remained within normal ranges. Only 1 patient
in the Advantage bileaflet group had patient-prosthesis-mismatch (PPM); there-
fore, evaluation of the results in this group was not relevant. CFR  coronary
flow reserve.
chocardiographic Data
Table 3 Echocardiographic Data
Hall Advantage
Mean gradient (mm Hg) at discharge 14 3 12 4
Mean gradient (mm Hg) at follow-up 11 3 11 4
LVM (g/m2) preoperatively 280 39 227 57
LVM (g/m2) at follow-up 174 44 186 51VM  left ventricular mass; NS  nonsignificant.eats/min·mm Hg; Freestyle 9,124  1,002 beats/min·mm
g; and Mosaic 10,489  1,120 beats/min·mm Hg).
The overall rate of perioperative complications was low in
ll groups. In the Hall group, 2 patients suffered from
emporary atrial fibrillation and 1 patient from a stroke at 8
onths after the operation. In the Advantage group, 1
atient required prolonged inotropic support and 1 patient
eveloped temporary atrial fibrillation. In the stentless
roup, we observed a case of AV-block grade III and needed
o implant a DDD pacemaker. In the stented group, there
as a case of pericardial effusion, which could be treated by
edication alone. There was no case of severe clinical events
r death in both groups either perioperatively or at the
-month follow-up.
New York Heart Association classification improved in
ll patients (mean 1.8  0.5 for Hall, 1.6  0.7 for
dvantage, 1.5 0.4 for stentless, and 1.7 0.4 for stented
alves at the follow-up). No patient was classified as New
ork Heart Association functional class IV.
iscussion
esides other variables, coronary artery flow is determined
y the diastolic flow pattern within the sinuses of Valsalva,
hich in native aortic valves is characterized by rounded
ackflow eddies enhancing aortic valve closure and forward
oronary flow. This natural low-turbulent flow pattern is
isturbed by any aortic valve substitute. In previous studies,
ownstream turbulence was dependent on valve design and
alve size (11). Therefore, it was logical that also coronary
ow was determined by these variables (10,11). The current
tudy adds the variable of valve size and thus effective orifice
rea, as it is known that adequate valve opening will allow
ess turbulent flow passage.
Long-term survival after AVR is limited by so-called
alve-related complications like thrombosis in mechanical
nd structural valve deterioration in biological substitutes.
y definition, the development of heart failure and sudden
ardiac deaths are not considered to be related to the
mplanted aortic valve, although these complications occur
n as many as 24% of the AVR patients within 10 years after
urgery (8,18). This incidence is significantly greater com-
ared with the background population; therefore, a connec-
ion between AVR and the risk of development of heart
ailure and arrhythmias can be presumed. Both might be
elated to an inadequate coronary perfusion because myo-
ardial blood flow impairment has been defined to be a
Mosaic Freestyle p Value
17 5 9 4 0.001 (Freestyle vs. Mosaic)
14.8 5.2 8.0 2.5 0.001 (Freestyle vs. Mosaic)
265 56 276 65 NS
191 54 159 70 NS
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ailure (19).
Indisputably, patients suffering from aortic stenosis dem-
nstrate impaired coronary perfusion; we even demon-
trated reversed flow during systolic ejection. This observa-
ion can be related on the one hand to a pathological
ressure relation between the left ventricle and the ascend-
ng aorta and on the other hand to Ventouri-type suction in
he aortic root caused by highly turbulent flow in aortic
tenosis. It was demonstrated before that AVR leads to
mprovement of coronary artery flow immediately but not to
complete normalization (9). In a previous animal study, we
ould show that no mechanical valve prosthesis could
estore the physiological values of coronary perfusion mea-
ured in a control group with a native aortic valve (12).
oronary flow rates depended on valve design and orienta-
ion. Because all mechanical and biological valves are
tenotic to some extent, it was not surprising that the
emaining flow obstruction also impaired coronary artery
ow analogous to aortic stenosis.
The current prospective randomized study was designed
o investigate the clinical impact of the findings. We
etermined not only the impact of valve design on coronary
ow, but also the role of the prosthetic aortic valve area
epresented by the iEOA. Coronary flow rates significantly
ncreased after AVR in each individual patient; a patholog-
cally reversed flow pattern could not be observed postop-
ratively. A more diastolic and thus physiological flow
istribution was observed. The decline of coronary perfu-
ion rates at 6 months postoperatively can be explained by
VMR and the normalization of cardiac output compared
ith the hyperdynamic phase immediately after the opera-
ion. We demonstrated that the 2 mechanical groups
ehaved rather similarly with respect to their hemodynamic
erformance and the coronary flow rates, including
ollow-up CFR. Thus, the Advantage valve matched the
emodynamic performance of the optimally orientated tilt-
ng disc prosthesis better than previously investigated bileaf-
et prostheses (20). This might be caused by the design
mprovement of a larger central orifice, which allows a more
qual flow distribution of eccentric systolic outflow (9–11).
oth mechanical valves could not reach the results of the 2
nvestigated biological valve designs. One reason might be
he inherent closing volume and leakage flow during the
iastolic phase, which interferes with the physiological
ackflow in the sinuses of Valsalva. The impact of flow
ynamics in the sinuses of Valsalva on coronary flow was
ecently demonstrated by Markl et al. (21) for patients who
ad undergone aortic valve repair under the different tech-
iques of Tirone David. Another reason might be the more
hysiological valve leaflet closure in biological valves, which
oth have 3 leaflets as the native human aortic valve.
In the biological groups, stentless valves demonstrated
ignificantly greater perfusion rates at discharge and follow-
p. Only stentless patients showed a normal flow reserve.
ransvalvular gradients and RPP as marker for myocardial flxygen demand and cardiac work load also were lower for
he Freestyle patients. Thus, the valve correcting the pres-
ure difference between the left ventricle and the aortic root
est provided the most physiological coronary flow as well.
he maintained annulus geometry and flexibility, as well as
he low resistance to transvalvular flow reducing the intra-
entricular pressure, might be the most important contrib-
tors to this result. Active annulus motion and its impact on
ow dynamics recently has been demonstrated by Lansac et
l. (22). The stentless valve imitates this natural geometry
loser than the stented valve; thus, backflow and sinus
urbulence is closer to normal physiology. It would be
nteresting to investigate the full-root technique of stentless
alve implantation, a technique that is intended to preserve
he geometry not only of the valve leaflets but also of the
ortic root.
Patient-prosthesis mismatch occurred in all groups. Only
ne patient demonstrated PPM in the Advantage group;
herefore, the evaluation of this group was not possible. For
he remaining prostheses, there was a correlation between
PM and reduction of CFR. However, for stentless valves,
his impairment did not lead to pathological results. For the
emaining tilting disc and stented biological valves, PPM
urther reduced the previously already decreased values.
A superior hemodynamic performance in combination
ith increased coronary artery flow and a normal flow
eserve may contribute to the observed lower midterm
ortality, which has been reported for stentless valve
esigns, especially if PPM is absent (23).
Because a major result this study draws attention on is the
nfluence of the type of aortic valve prosthesis on coronary
erfusion, especially CFR, this property should be included
n investigations regarding the hemodynamic performance
f mechanical and biological valve prostheses in the future.
mpaired CFR might influence left ventricular function,
usceptibility for arrhythmias and, finally, exercise tolerance.
owever, the current study did not prove definitely any
linical relevance of impaired CFR on later outcome. It is
ossible that the flow obtained from all 4 valve prostheses is
till adequate. Further studies with larger patient cohorts
hould investigate its impact on late myocardial morbidity
nd survival rates.
tudy limitations. Regarding limitations, we included a
mall number of patients in this study. In part, the negative
ffect of postoperative arrhythmia on MRI quality postop-
ratively is another limitation. Atrial fibrillation at the time
f discharge was present in 3 patients in the Freestyle group,
patients in the Mosaic group, 1 patient in the Hall group,
nd 1 patient in Advantage group. In all of these patients,
ate control was achieved before the MRI scan by antiar-
hythmic medication. Fortunately, these patients did not
emonstrate arrhythmias at the follow-up examination.
rom a surgical perspective, longer follow-up periods and
lso a greater number of patients are necessary to purport
ny long-term advantage of better flow pattern and higher
ow velocity in different valve substitutes.
R
D
W
6
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
796 Bakhtiary et al. JACC Vol. 49, No. 7, 2007
Aortic Valve Replacement and Coronary Flow Reserve February 20, 2007:790–6eprint requests and correspondence: Dr. Farhad Bakhtiary,
epartment of Thoracic and Cardiovascular Surgery, Johann
olfgang Goethe University Hospital, Theodor-Stern-Kai 7,
0596 Frankfurt/Main, Germany. E-mail: farhad@bakhtiary.de.
EFERENCES
1. Kume T, Akasaka T, Kawamoto T, et al. Mechanisms of impaired
coronary flow reserve in patients with aortic stenosis: transthoracic
Doppler echocardiographic study. J Cardiol 2004;43:173–8.
2. Britten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in
angiographically normal or mildly diseased coronary arteries predicts
adverse cardiovascular long-term outcome. Coron Artery Dis 2004;15:
259–64.
3. Emery RW, Erickson CA, Arom KV, et al. Replacement of the aortic
valve in patients under 50 years of age: long-term follow-up of the St.
Jude Medical prosthesis. Ann Thorac Surg 2003;75:1815–9.
4. Dellgren G, Eriksson MJ, Brodin LA, Radegran K. Eleven years’
experience with the Biocor stentless aortic bioprosthesis: clinical and
hemodynamic follow-up with long-term relative survival rate. Eur
J Cardiothorac Surg 2002;22:912–21.
5. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results
of heart valve replacement with the Hancock II bioprosthesis. J Thorac
Cardiovasc Surg 2001;121:268–77.
6. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski
H. Late hemodynamic and clinical outcomes of aortic valve replace-
ment with the Carpentier-Edwards Perimount pericardial bioprosthe-
sis. J Thorac Cardiovasc Surg 2002;124:146–54.
7. Blackstone EH, Cosgrove DM, Jamieson WR, et al. Prosthesis size
and long-term survival after aortic valve replacement. J Thorac
Cardiovasc Surg 2003;126:783–96.
8. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P.
Impact of valve prosthesis-patient mismatch on short-term mortality
after aortic valve replacement. Circulation 2003;108:983–8.
9. Kleine P, Klesius, AA, Scherer M, Abdel-Rahman U, Moritz A.
Initial in vivo results of the new Medtronic Advantage™ bileaflet valve
in aortic position and comparison to the SJM. Cardiovasc Surg
2002;10:494.
0. Kleine P, Abdel-Rahman U, Klesius AA, Scherer M, Moritz A.
Comparison of hemodynamic performance of: Medtronic Hall 21 mm
versus St. Jude Medical 23 mm prostheses in pigs. J Heart Valve Dis
2002;11:857–63.1. Kleine P, Scherer M, Abdel-Rahman U, Klesius AA, Moritz A. Effect
of mechanical aortic valve orientation on coronary artery flow: com-
parison of tilting disc versus bileaflet prostheses in pigs. J Thorac
Cardiovasc Surg 2002;124:925–32.
2. Scherer M, Abdel-Rahman U, Dzemali O, et al. Pathophysiology of
coronary artery flow during extracorporeal circulation (ECC), myocar-
dial ischemia and mechanical aortic valve replacement—an experimen-
tal study. Cardiology 2005;1:30–35.
3. Stauder NI, Stauder H, Fenchel M, et al. MR angiography and
determination of the flow reserve after minimal invasive direct coro-
nary artery bypass (MIDCAB) surgery of the left internal mammary
artery in comparison to multirow CT. Rofo 2005;177:1094–102.
4. Schiemann M, Bakhtiary F, Hietschold V, et al. MR-based coronary
artery blood velocity measurements in patients without coronary artery
disease. Eur Radiol 2006;16:1124–30.
5. Dalla GE, Wilkinson L. An analytic approximation to the distribution
of Lilliefors’ test statistic for normality. Am Stat 1986;40:294–6.
6. Kleine P, Perthel M, Nygaard H, et al. Medtronic Hall versus St. Jude
Medical mechanical aortic valve: downstream turbulences with respect
to rotation in swine. J Heart Valve Dis 1998;7:548–55.
7. Seitelberger R, Bialy J, Gottardi R, et al. Relation between size of
prosthesis and valve gradient: comparison of two aortic bioprosthesis.
Eur J Cardiothorac Surg 2004;25:358–63.
8. Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Bortier H.
Risk factors for congestive heart failure after aortic valve replacement
with a Carpentier-Edwards pericardial prosthesis in the elderly.
J Heart Valve Dis 2005;14:774–9.
9. Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of
myocardial blood flow impairment in idiopathic left ventricular dys-
function. Circulation 2002;105:186–93.
0. Kleine P, Hasenkam JM, Nygaard H, Perthel M, Wesemeyer D, Laas
J. Tilting disc versus bileaflet aortic valve substitutes—intraoperative
and postoperative hemodynamic performance in human. J Heart Valve
Dis 2000;9:308–12.
1. Markl M, Draney MT, Miller DC, et al. Time-resolved 3-D magnetic
resonance velocity mapping of aortic flow in healty volunteers and
patients after valve-sparing aortic root replacement. J Thorac Cardio-
vasc Surg 2005;130:456–63.
2. Lansac E, Lim HS, Shomura Y, et al. A four dimensional study of the
aortic root dynamics. Eur J Cardiothoracic Surg 2002;22:497–503.
3. Ennker J, Rosendahl U, Albert A, Dumlu E, Ennker IC, Florath I.
Stentless bioprostheses in small aortic roots: impact of patient-
prosthesis mismatch on survival and quality of life. J Heart Valve Dis
2005;14:523–30.
